Well, you don't have to die wondering on the "what if?" - jut mosey on over to OPT's capital raise done at the same time for double the CR, half the discount, a third of the decline in share price after open trade..............and a large tranche in non-dilutive funding to see them through to commercialization.
And coverage in the US biotech publications.
2 co-leads in the raise - US & Australia. Same market cap - same stage (p3) in development.
Almost like a super industry fund TV ad.
research reports and media, page-3148
-
- There are more pages in this discussion • 1,255 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $76.95M | |||
| Open | High | Low | Value | Volume |
| 22.5¢ | 23.5¢ | 22.0¢ | $65.40K | 290.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 96390 | 22.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.5¢ | 138166 | 5 |
View Market Depth
| Last trade - 16.10pm 15/08/2024 (20 minute delay) ? |
| PAR (ASX) Chart |